Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-07

Clinical Trial Update: Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating normothermic machine perfusion for kidney transplant outcomes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Erasmus Medical Center | Conditions: Kidney Transplant Failure, Chronic Kidney Failure | Phase 2 | Status: ACTIVE_NOT_RECRUITING